ロード中...
Treatment Outcomes and Tolerability Following Initiation of GLP-1 Receptor Agonists Among Type 2 Diabetes Patients in Primary Care Practices in Germany
BACKGROUND: The aim was to investigate real-world treatment outcomes and tolerability of GLP-1 receptor agonist (GLP-1RA) therapy in patients with type 2 diabetes in Germany. METHODS: Patients from 323 primary care practices who started any GLP-1RA therapy (89 Byetta, 108 Bydureon, 347 Victoza patie...
保存先:
| 出版年: | J Diabetes Sci Technol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5478013/ https://ncbi.nlm.nih.gov/pubmed/27470665 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1932296816661349 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|